Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01390116 · ClinicalTrials.gov registry record · NA
The Effect of Aged Garlic Extract Supplementation on Immune System
A NA study of Improvement in Immune Cell Function in Healthy Humans, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT01390116: Completed NA study of Improvement in Immune Cell Function in Healthy Humans, sponsored by University of Florida.
NCT01390116 is a NA study of Improvement in Immune Cell Function in Healthy Humans that has completed, run by University of Florida. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01390116, a NA study of Improvement in Immune Cell Function in Healthy Humans, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether consuming capsules of aged garlic extract is effective in enhancing function of NK and/or γδ T cell resulting in fewer cold and flu symptoms.
Primary Outcome
The ability of the natural killer and/or γδ T cells to proliferate when cultured ex vivo.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Aged garlic extract
- DIETARY_SUPPLEMENT AGE
Study Locations (1)
Florida
- 449 Food Science and Human Nutrition Department - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-05 |
| Phase | NA |
What the finished NCT01390116 record still lists
NCT01390116 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Improvement in Immune Cell Function in Healthy Humans appearing as the primary indexed condition, and to 2 interventions - of which Aged garlic extract is the first listed.
NCT01390116 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01390116 about?
NCT01390116 is a clinical study titled "The Effect of Aged Garlic Extract Supplementation on Immune System". The purpose of this study is to determine whether consuming capsules of aged garlic extract is effective in enhancing function of NK and/or γδ T cell resulting in fewer cold and flu symptoms.
What is the current status of trial NCT01390116?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2010-02. Estimated completion is 2010-05.
What conditions does trial NCT01390116 study?
This clinical trial studies the following conditions: Improvement in Immune Cell Function in Healthy Humans.
What interventions are being tested in trial NCT01390116?
The interventions under investigation include: Aged garlic extract (DIETARY_SUPPLEMENT), AGE (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01390116?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01390116 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01390116's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia